β-oxo-Cyclopropylpropanenitrile is used in the synthesis of novel 5-amino pyrazole derivatives against carcinogenesis present in breast cancer cell lines. Also aids in the structure based design and synthesis of N-pyrazole and N’-thiazole urea inhibitors of MAP kinase p38α.